Hospital Universitario de Getafe began coordinating European research projects on frailty in 2010, when the Foundation was the developmental organizing body for projects. At present, the Foundation leads 5 European projects on frailty, with a value of €25 million, and coordinates 25 groups from 9 European countries and the WHO. The first of these 5 projects, MID FRAIL, which was funded by the Seventh Framework Programme for Research of the European Commission (FP7), was started in 2012 and has recently been completed. In 2013, this was followed by FRAILOMIC, which was also funded by FP7. FRAILCLINIC, which was funded by the Second Health Programme of the European Commission, was started in 2014. A further 2 projects were added in 2015, namely, FRAILTOOLS, funded by the III Programme for Health of the Commission, and the ADVANTAGE Joint Action on the Prevention of Frailty, whose coordination was entrusted to the Madrid Health Service–Fundación para la Investigación Biomédica del Hospital Universitario de Getafe by the European Commission.
Within the area of aging, our institution also participates as a partner in a further 5 projects. Since 2014, it has been involved in SPRINTT, which falls within the Innovative Medicines Initiative, and since 2015, in ACANTO and DECI, which are funded by Horizonte 2020, and VIVIFRAIL, under the European Erasmus+ programme. Since 2015, our hospital has also been participating in the FACET project, within the framework of EIT Health, one of the Knowledge and Innovation Communities (KICs) promoted by the European Institute of Innovation and Technology (EIT).
Since its creation in 2013, Fundación del Hospital Universitario de Getafe has participated in EIT Health, a consortium sponsored by EIT and created in 2015. EIT Health comprises 144 companies, universities, and research centers from 14 European countries, with a total budget of €2100 million. Spain participates as one of the 6 nodes (“co-location centers”), with Madrid as a sub-node. The Health Ministry, with the support of the Viceconsejería de Ordenación e Investigación (Vice-Council for Research and Management), has cooperated actively in this venture through an agreement between 7 of the Biomedical Research Foundations of hospitals in Madrid under the leadership of the Fundación para la Investigación Biomédica del Hospital Universitario de Getafe. The FACET project is currently the first project in which our hospital participates in the calls for projects launched by the consortium.
In parallel, our hospital has considerably increased its active participation in several European initiatives in the field of clinical research:
The European Innovation Partnership on Active and Healthy Ageing (EIP-AHA) has the double objective of (1) establishing major strategic alliances with some of the more relevant stakeholders in European research and (2) placing ourselves in a privileged situation with the aim of setting future priorities for the European Union in the field of biomedical research, mainly in those areas of greatest interest for our hospital. The Fundación para la Investigación Biomédica del Hospital Universitario de Getafe participates actively in the 6 working groups of the EIP-AHA through its leadership of the Frailty Group.
Through Hospital Universitario de Getafe, the Autonomous Community of Madrid is a key member of the Reference Site Collaborate Network (RSCN), which comprises more than 30 reference sites. In 2013, the Autonomous Community of Madrid-Hospital Universitario de Getafe received a 3-star award, the highest within this network.
Another significant milestone is the ADVANTAGE Joint Action for the Prevention of Frailty, whose coordination was awarded by the European Commission to the Servicio Madrileño de Salud-Hospital Universitario de Getafe. ADVANTAGE is part of the Third Health Programme 2014-2020 and receives a subsidy from the European Union worth €3.5 million. For the period 2017-2019, it comprises 34 organizations from 24 European countries.
Although the development of European projects has slowed somewhat in recent years, it is important to devote a specific section to this area, since the amounts involved in and the type of management associated with the projects when an organization acts as a coordinator (as is the case with various projects at Hospital Universitario de Getafe) is not reflected in the graph showing absolute figures.
The following graph shows the development of the research projects active at the end of each period.
The following image shows the development of clinical trials and observational studies active in 2016.